79 related articles for article (PubMed ID: 7528489)
21. [Acceleration of the regeneration of skeletal muscles in adult rats by dextran derivatives].
Gautron J; Kedzia C; Husmann I; Barritault D
C R Acad Sci III; 1995 Jun; 318(6):671-6. PubMed ID: 7545528
[TBL] [Abstract][Full Text] [Related]
22. Matrix glycosaminoglycans in the growth phase of fibroblasts: more of the story in wound healing.
Kosir MA; Quinn CC; Wang W; Tromp G
J Surg Res; 2000 Jul; 92(1):45-52. PubMed ID: 10864481
[TBL] [Abstract][Full Text] [Related]
23. Bioactive cell-derived matrices combined with polymer mesh scaffold for osteogenesis and bone healing.
Kim IG; Hwang MP; Du P; Ko J; Ha CW; Do SH; Park K
Biomaterials; 2015 May; 50():75-86. PubMed ID: 25736498
[TBL] [Abstract][Full Text] [Related]
24. Heal thyself: using endogenous regeneration to repair bone.
Alman BA; Kelley SP; Nam D
Tissue Eng Part B Rev; 2011 Dec; 17(6):431-6. PubMed ID: 21682602
[TBL] [Abstract][Full Text] [Related]
25. The use of heparan sulfate to augment fracture repair in a rat fracture model.
Jackson RA; McDonald MM; Nurcombe V; Little DG; Cool SM
J Orthop Res; 2006 Apr; 24(4):636-44. PubMed ID: 16514633
[TBL] [Abstract][Full Text] [Related]
26. Mesenchymal stem cells, neural lineage potential, heparan sulfate proteoglycans and the matrix.
Okolicsanyi RK; Griffiths LR; Haupt LM
Dev Biol; 2014 Apr; 388(1):1-10. PubMed ID: 24509075
[TBL] [Abstract][Full Text] [Related]
27. Effect of substituted dextran derivative on complement activation in vivo.
Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD
Biomaterials; 1995 Oct; 16(15):1163-7. PubMed ID: 8562793
[TBL] [Abstract][Full Text] [Related]
28. Growth factors and bone regeneration. Implications of barrier membranes.
Zellin G
Swed Dent J Suppl; 1998; 129():7-65. PubMed ID: 9672999
[TBL] [Abstract][Full Text] [Related]
29. Inhibition by dextran derivatives of FGF-2 plasmin-mediated degradation.
Meddahi A; Lemdjabar H; Caruelle JP; Barritault D; Hornebeck W
Biochimie; 1995; 77(9):703-6. PubMed ID: 8789459
[TBL] [Abstract][Full Text] [Related]
30. Removal of heparan sulfate by heparinase treatment inhibits FGF-2-dependent smooth muscle cell proliferation in injured rat carotid arteries.
Kinsella MG; Irvin C; Reidy MA; Wight TN
Atherosclerosis; 2004 Jul; 175(1):51-7. PubMed ID: 15186946
[TBL] [Abstract][Full Text] [Related]
31. Heparan sulfate primed on beta-D-xylosides restores binding of basic fibroblast growth factor.
Miao HQ; Fritz TA; Esko JD; Zimmermann J; Yayon A; Vlodavsky I
J Cell Biochem; 1995 Feb; 57(2):173-84. PubMed ID: 7759555
[TBL] [Abstract][Full Text] [Related]
32. Topical secretoneurin gene therapy accelerates diabetic wound healing by interaction between heparan-sulfate proteoglycans and basic FGF.
Albrecht-Schgoer K; Schgoer W; Theurl M; Stanzl U; Lener D; Dejaco D; Zelger B; Franz WM; Kirchmair R
Angiogenesis; 2014 Jan; 17(1):27-36. PubMed ID: 23918206
[TBL] [Abstract][Full Text] [Related]
33. Matrix therapy in regenerative medicine, a new approach to chronic wound healing.
Barbier-Chassefière V; Garcia-Filipe S; Yue XL; Kerros ME; Petit E; Kern P; Saffar JL; Papy-Garcia D; Caruelle JP; Barritault D
J Biomed Mater Res A; 2009 Sep; 90(3):641-7. PubMed ID: 18563829
[TBL] [Abstract][Full Text] [Related]
34. Temporal expression of proteoglycans in the rat limb during bone healing.
Song SJ; Hutmacher D; Nurcombe V; Cool SM
Gene; 2006 Sep; 379():92-100. PubMed ID: 16842937
[TBL] [Abstract][Full Text] [Related]
35. Heparan sulfate proteoglycans including syndecan-3 modulate BMP activity during limb cartilage differentiation.
Fisher MC; Li Y; Seghatoleslami MR; Dealy CN; Kosher RA
Matrix Biol; 2006 Jan; 25(1):27-39. PubMed ID: 16226436
[TBL] [Abstract][Full Text] [Related]
36. Extracellular modulation of Fibroblast Growth Factor signaling through heparan sulfate proteoglycans in mammalian development.
Matsuo I; Kimura-Yoshida C
Curr Opin Genet Dev; 2013 Aug; 23(4):399-407. PubMed ID: 23465883
[TBL] [Abstract][Full Text] [Related]
37. Interaction of fibroblast growth factor-1 and related peptides with heparan sulfate and its oligosaccharides.
Fromm JR; Hileman RE; Weiler JM; Linhardt RJ
Arch Biochem Biophys; 1997 Oct; 346(2):252-62. PubMed ID: 9343372
[TBL] [Abstract][Full Text] [Related]
38. The effect of matrix metalloproteinase inhibition on tendon-to-bone healing in a rotator cuff repair model.
Bedi A; Kovacevic D; Hettrich C; Gulotta LV; Ehteshami JR; Warren RF; Rodeo SA
J Shoulder Elbow Surg; 2010 Apr; 19(3):384-91. PubMed ID: 19800260
[TBL] [Abstract][Full Text] [Related]
39. RGTA OTR4120, a heparan sulfate mimetic, is a possible long-term active agent to heal burned skin.
Garcia-Filipe S; Barbier-Chassefiere V; Alexakis C; Huet E; Ledoux D; Kerros ME; Petit E; Barritault D; Caruelle JP; Kern P
J Biomed Mater Res A; 2007 Jan; 80(1):75-84. PubMed ID: 16958049
[TBL] [Abstract][Full Text] [Related]
40. Syndecan-3 and syndecan-4 specifically mark skeletal muscle satellite cells and are implicated in satellite cell maintenance and muscle regeneration.
Cornelison DD; Filla MS; Stanley HM; Rapraeger AC; Olwin BB
Dev Biol; 2001 Nov; 239(1):79-94. PubMed ID: 11784020
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
